VIAD

VIAD

SIF 167 VIAD

Project Manager: Jayakrishna Ambati

Virginia Initiative for Accelerating Drugs (VIAD): The purpose of this award is to identify drug repurposing candidates through use of data analytics.

BoV Approved: Fall 2019

Project Dates: 

Funding Awarded: $1,000,000

Executive Summary

Identifying new therapies for diseases that have no adequate treatments is among the great challenges facing modern medicine. The overwhelming majority of potential therapeutic compounds fail in the current “one drug – one target – one disease” testing paradigm. A promising complementary approach to drug development is finding new uses for existing medicines, known as drug repurposing. The mission of the proposed Virginia Initiative for Accelerating Drugs (VIAD), part of the University of Virginia, is to unleash the full spectrum of therapeutic activities of drugs by creating and implementing a paradigm-inverting Big Data archaeological approach to drug development that enables novel patentable entities, expedites repurposing, and launches unimaginable avenues of transdisciplinary collaborative scientific exploration. 

VIAD will support its mission by utilizing novel healthcare data analytics to identify drug repurposing candidates. This exciting effort will also support the development of a network of faculty and organizations across Grounds, including the School of Medicine and the Licensing & Ventures Group to advance the University’s educational mission. VIAD will attract preeminence to the University by establishing a new template for drug development in the 21st century to radically improve healthcare outcomes in the Commonwealth and beyond.

Current Status: Active

Progress

This award will be reviewed by the PAC at their December 2020 meeting.